Biogen Inc
NASDAQ:BIIB

Watchlist Manager
Biogen Inc Logo
Biogen Inc
NASDAQ:BIIB
Watchlist
Price: 157.9 USD -0.07% Market Closed
Market Cap: 23B USD
Have any thoughts about
Biogen Inc?
Write Note

P/OCF
Price to OCF

10.8
Current
18.1
Median
21.6
Industry
Lower than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
10.8
=
Market Cap
23B USD
/
Operating Cash Flow
2.1B USD
All Countries
Close
Market Cap P/OCF
US
Biogen Inc
NASDAQ:BIIB
23B USD 10.8
FR
Pharnext SCA
OTC:PNEXF
6T USD -239 316.7
US
Abbvie Inc
NYSE:ABBV
312.7B USD 18.9
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 21.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD -137.9
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 11.2
US
Epizyme Inc
F:EPE
94.1B EUR -470.1
AU
CSL Ltd
ASX:CSL
133.6B AUD 31.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 19.1
US
Seagen Inc
F:SGT
39.3B EUR -75.9
NL
argenx SE
XBRU:ARGX
34.5B EUR -138.6

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A

See Also

Discover More